News
The Josep Carreras Foundation and Sant Joan de Déu Create a Childhood Leukemia Research Program Worth Over 10 Million Euros
The Josep Carreras Foundation (FJC), the Josep Carreras Leukemia Research Institute (IJC), and the Sant Joan de Déu Research Institute (IRSJD) have agreed to develop a joint research program on childhood leukemia valued at over 10 million euros.
Genetic risk for psychiatric disorders is related to emotional and behavioral problems in undiagnosed children
Genetic susceptibility to developing ADHD shows the strongest association with mental problems during childhood and adolescence compared to genetic risk for other psychiatric conditions.
An aggressive childhood cancer case opens new avenues for advanced cell therapies
A positive response to therapy in a paediatric patient with a renal rhabdoid tumour has enabled researchers to identify immune cells with anti-tumour activity in this rare cancer.
A study led by Sant Joan de Déu shows promising results for a new treatment for childhood cerebral adrenoleukodystrophy
An international study led by Sant Joan de Déu explores the first oral therapy to slow childhood cerebral adrenoleukodystrophy, a devastating rare disease.
Agenda
TECSAM | Regulació comparada: EUA i UE. Claus reguladores per a l'accés al mercat
Talyta Carteano, Medical Device Director a Asphalion.
Interviews
Manel González-Piñero
Headof Innovation at CREB UPC and XarTEC SALUT
"Our main objectives are to develop a technologies map of the members of XarTEC SALUT and to find the most effective ways to support them."
Read more More Interviews
